Abeona Therapeutics Inc (ABEO)

04:30 AM

Abeona Therapeutics (ABEO) director reports bona fide 500-share gift - Stock Titan

04:30 AM

08:44 AM

Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences - The Manila Times

08:44 AM

08:36 AM

Abeona plans Jefferies fireside chat, Goldman investor meetings - Stock Titan

08:36 AM

May 23, 2026

Lightning eMotors Inc. (ZEV) - Minichart

May 23, 2026

May 22, 2026

Insider Sell: Mark Alvino Sells 6,500 Shares of Abeona Therapeutics Inc (ABEO) - GuruFocus

May 22, 2026

May 22, 2026

Abeona Therapeutics director Mark Alvino sells $35,462 in stock By Investing.com - Investing.com South Africa

May 22, 2026

May 22, 2026

Abeona Therapeutics director Mark Alvino sells $35,462 in stock - Investing.com UK

May 22, 2026

May 22, 2026

Abeona Therapeutics (ABEO) director sells 6,500 shares in open-market trade - Stock Titan

May 22, 2026

May 22, 2026

[144] ABEONA THERAPEUTICS INC. SEC Filing - Stock Titan

May 22, 2026

May 22, 2026

May 2026's Top Insider-Owned Growth Companies - simplywall.st

May 22, 2026

May 22, 2026

symbol__ Stock Quote Price and Forecast - CNN

May 22, 2026

May 20, 2026

Abeona Therapeutics (NASDAQ: ABEO) Reports $8.7 Million in Q1 Revenue as ZEVASKYN Adoption Accelerates - foreignpolicyjournal.com

May 20, 2026

May 20, 2026

Abeona Therapeutics Highlights Strong ZEVASKYN Launch Momentum - TipRanks

May 20, 2026

May 18, 2026

Daily Brief Health Care: Dermavon Holdings, Alebund Pharmaceuticals Jiangsu, Alnylam Pharmaceuticals, Artrya , Bavarian Nordic A/S, Cardinal Health, Dexcom Inc, American Shared Hospital Servi, Eli Lilly & Co, Abeona Therapeutics and more - Smartkarma

May 18, 2026

May 18, 2026

(ABEO) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily

May 18, 2026

May 18, 2026

ABEO: Three Patients Treated in 1Q26 with Two Additional QTCs Activated - Zacks Small Cap Research

May 18, 2026

May 18, 2026

Earnings call transcript: Abeona Therapeutics beats Q1 2026 forecasts, stock dips By Investing.com - Investing.com South Africa

May 18, 2026

May 18, 2026

Earnings call transcript: Abeona Therapeutics beats Q1 2026 forecasts, stock dips - Investing.com

May 18, 2026

May 16, 2026

Abeona Therapeutics | SCHEDULE 13G/A: Others - Moomoo

May 16, 2026

May 16, 2026

Abeona Therapeutics Q1 2026 earnings preview - MSN

May 16, 2026

May 15, 2026

Abeona (ABEO) director 10b5-1 open-market sale of 26,143 shares - Stock Titan

May 15, 2026

May 15, 2026

Nantahala (ABEO) reports 5.78M-share 9.99% stake; managers Harkey, Mack listed - Stock Titan

May 15, 2026

May 15, 2026

Nantahala Capital reports 3.33M shares in Abeona (ABEO) as of March 31, 2026 - Stock Titan

May 15, 2026

May 15, 2026

ABEO (Nasdaq) Form 144: Insider proposes sale; restricted awards listed - Stock Titan

May 15, 2026

May 15, 2026

Jefferies Remains a Buy on Abeona Therapeutics (ABEO) - The Globe and Mail

May 15, 2026

May 15, 2026

Abeona Therapeutics (ABEO) Gets a Buy from Oppenheimer - The Globe and Mail

May 15, 2026

May 14, 2026

Abeona Therapeutics Inc. (NASDAQ:ABEO) Q1 2026 Earnings Call Transcript - Insider Monkey

May 14, 2026

May 14, 2026

Abeona Therapeutics Q1 2026 Earnings Call: Complete Transcript - Sahm

May 14, 2026

May 14, 2026

Abeona Reports Strong Q1 Revenue, Expands Treatment Center Network - Sahm

May 14, 2026

May 14, 2026

H.C. Wainwright Maintains Abeona Therapeutics(ABEO.US) With Buy Rating, Maintains Target Price $20 - Moomoo

May 14, 2026

May 13, 2026

Abeona Therapeutics Inc (ABEO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic Expansions - GuruFocus

May 13, 2026

May 13, 2026

Abeona Therapeutics Signals Strong Early ZEVASKYN Launch - TipRanks

May 13, 2026

May 13, 2026

Abeona Therapeutics Q1 2026 Earnings Call Transcript - MarketBeat

May 13, 2026

May 13, 2026

Abeona (ABEO) Q1 2026 Earnings Transcript - The Globe and Mail

May 13, 2026

May 13, 2026

Earnings Call Summary | Abeona Therapeutics(ABEO.US) Q1 2026 Earnings Conference - Moomoo

May 13, 2026

May 13, 2026

Abeona Therapeutics Q1 2026: Loss Narrows to $0.30/Share - AlphaStreet

May 13, 2026

May 13, 2026

Abeona Therapeutics (ABEO) Reports Strong Q1 Earnings with Reven - GuruFocus

May 13, 2026

May 13, 2026

Abeona Therapeutics Q1 Earnings Call Highlights - sharewise.com

May 13, 2026

May 13, 2026

Abeona Therapeutics Inc. Q1 2026 Financial Report: Key Highlights, Risk Factors, and ZEVASKYN Commercialization Update - Minichart

May 13, 2026

May 13, 2026

Abeona Therapeutics earnings beat by $0.04, revenue topped estimates - Investing.com Canada

May 13, 2026

May 13, 2026

Abeona Therapeutics Releases Q1 2026 Financial Results - AlphaStreet

May 13, 2026

May 13, 2026

Abeona Therapeutics Reports Q1 2026 Results: Strong ZEVASKYN Adoption, Pipeline Focus on PSMA T-Cell Therapy, and $168M Cash Position - Minichart

May 13, 2026

May 13, 2026

Earnings call transcript: Abeona Therapeutics Q1 2026 beats expectations with strong revenue - Investing.com

May 13, 2026

May 13, 2026

Earnings call transcript: Abeona Therapeutics Q1 2026 beats expectations with strong revenue By Investing.com - Investing.com South Africa

May 13, 2026

May 13, 2026

Abeona Therapeutics (ABEO) Reports Strong Q1 Revenue Growth - GuruFocus

May 13, 2026

May 13, 2026

ABEO: Q1 revenue surged on ZEVASKYN uptake; profitability targeted by June; pipeline expands to oncology - TradingView

May 13, 2026

May 13, 2026

Abeona Therapeutics Deprioritizes In-House Ophthalmology Programs >ABEO - Moomoo

May 13, 2026

May 13, 2026

Is Abeona Therapeutics (ABEO) Appropriately Valued After a Q1 20 - GuruFocus

May 13, 2026